Home Newsletters ESC & iPSC News Development of iPSC-Based Clinical Trial Selection Platform for Patients with Ultrarare Diseases

Development of iPSC-Based Clinical Trial Selection Platform for Patients with Ultrarare Diseases

0
Scientists reported an 18-year-old patient with ultrarare Leigh-like syndrome. They established an iPSC–based platform for this patient, and assessed the efficacy of a panel of drugs.
[Science Advances]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version